Cost of antihypertensive treatment: a point of view from India.
In India, expenditure on the treatment of all patients with mild hypertension is not cost effective. Nonpharmacologic treatment is encouraged.
Bali
H K
HK
Department of Cardiology, Postgraduate Institute of Medical Education & Research, Chandigarh, India.
Anand
I S
IS
D003362:Cost-Benefit Analysis; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000191:economics* / Q000628:therapy; D007194:India